ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Precise quantitative evaluation of pharmacokinetics of cisplatin using a radio-platinum tracer in tumor-bearing mice

https://repo.qst.go.jp/records/2000221
https://repo.qst.go.jp/records/2000221
9e0359fd-f4b9-47d9-a069-043685476467
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2023-06-28
タイトル
タイトル Precise quantitative evaluation of pharmacokinetics of cisplatin using a radio-platinum tracer in tumor-bearing mice
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Obata Honoka

× Obata Honoka

Obata Honoka

Search repository
Tsuji Atsushi

× Tsuji Atsushi

Tsuji Atsushi

Search repository
Sudo Hitomi

× Sudo Hitomi

Sudo Hitomi

Search repository
Sugyo Aya

× Sugyo Aya

Sugyo Aya

Search repository
Minegishi Katsuyuki

× Minegishi Katsuyuki

Minegishi Katsuyuki

Search repository
Nagatsu Kotaro

× Nagatsu Kotaro

Nagatsu Kotaro

Search repository
Ogawa Mikako

× Ogawa Mikako

Ogawa Mikako

Search repository
Zhang Ming-Rong

× Zhang Ming-Rong

Zhang Ming-Rong

Search repository
抄録
内容記述タイプ Abstract
内容記述 Objective The platinum-based antineoplastic drug cisplatin is commonly used for chemotherapy in clinics. This work aims to demonstrate a radio-platinum tracer is useful for precisely quantifying small amounts of platinum in pharmacokinetics studies.
Methods A cisplatin radiotracer (radio-cisplatin) was synthesized, and a comprehensive evaluation of cisplatin over 7 days after its intravenous injection into nude mice bearing a subcutaneous lung tumor (H460) was conducted.
Results A biphasic retention curve in the whole body and blood was observed [T1/2(α) = 1.14 h, T1/2(β) = 5.33 days for the whole body, and
T1/2(α) = 23.9 min, T1/2(β) = 4.72 days for blood]. The blood concentration decreased within 1 day after injection.
Most of the intact cisplatin was excreted via the kidneys in the early time points, and a small part was distributed in tissues including tumors. The plasma protein binding rate of cisplatin increased rapidly after injection, and the protein-bound cisplatin remained in the blood longer than intact cisplatin. The peak uptake in H460 tumors was 4.7% injected dose per gram at 15 min after injection, and the
area under the curve (AUC0?7 days) was approximately onehalf to one-third of the AUC0?7 days in the kidneys, liver, and bone, where some toxicity is observed in humans.
Conclusion The radio-platinum tracer revealed the highly quantitative biodistribution of cisplatin, providing insights into the properties of cisplatin, including its adverse effects. The tracer enables a precise evaluation
of pharmacokinetics for platinum-based drugs with high sensitivity. Nucl Med Commun XXX: 000?000 Copyright c
2022 The Author(s). Published by Wolters Kluwer Health, Inc.
書誌情報 Nuclear Medicine Communications

巻 43, 号 11, p. 1121-1127, 発行日 2022-11
出版者
出版者 LIPPINCOTT WILLIAMS & WILKINS
ISSN
収録物識別子タイプ ISSN
収録物識別子 1473-5628
PubMed番号
識別子タイプ PMID
関連識別子 36120823
DOI
識別子タイプ DOI
関連識別子 10.1097/MNM.0000000000001614
戻る
0
views
See details
Views

Versions

Ver.1 2025-08-15 01:24:24.583598
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3